Neurosearch

3 Pipeline Obesity Treatments You Should Watch
Motley Fool
Thu, 05/23/13 - 12:03 pm
obesity
Vivus
Orexigen
Contrave
Belviq
tesofensine
Neurosearch
Qsymia
Arena Pharmaceuticals
Teva acquires Huntexil development programme rights from NeuroSearch
Pharmabiz
Sat, 09/29/12 - 12:58 pm
Teva Pharmaceuticals
Huntexil
Neurosearch
Huntington's disease
Teva Pharma acquires rights to Huntexil for $26M
Yahoo/AP
Fri, 09/28/12 - 10:35 am
Teva Pharmaceuticals
Huntexil
Huntington's disease
Neurosearch
MermaiHD Madness: NeuroSearch's Statistically Significant Snafu
InVivo
Wed, 04/28/10 - 09:17 am
MermaiHD
Neurosearch
Huntington's disease
GSK: Rare Diseases Now Big Business
WSJ Online
Mon, 02/8/10 - 12:35 pm
GSK
Prosensa
Neurosearch
JCS Pharmaceuticals
Amicus Therapeutics
Aldagen
NeuroSearch announces drug discovery and drug development alliance with Janssen Pharmaceutica NV
Neurosearch Press Release
Mon, 08/17/09 - 10:56 am
Neurosearch
Janssen Pharmaceuticals
partnerships
drug discovery
NeuroSearch: Experimental Obesity Drug to Begin Phase 3 Trials
Seeking Alpha
Wed, 06/10/09 - 08:28 am
Neurosearch
obesity
Arena Pharmaceuticals
drug trials
Vivus
Orexigen
tesofensine
Lilly to boost biotech stake in NeuroSearch deal
PharmaFocus
Tue, 02/17/09 - 11:15 am
Eli Lilly
biotech
Neurosearch
For Antidepressants, Maybe Three Targets Will Be Better than Two
WSJ Online
Tue, 02/10/09 - 07:07 am
antidepressants
TRIs
Neurosearch
AstraZeneca
Bristol-Myers Squibb
Dov